• Redx Joins Panel of Experts at the 8th IPF Summit in Boston

    Read more
  • Redx Reports Encouraging Zamaporvint Phase 2 Data

    Read more
  • Redx to Present Zamaporvint Phase2 Data at ESMO GI

    Read more
  • Redx to Present Preclinical Data on RXC008 in an Oral Presentation at ECM Congress

    Read more
  • Redx Confirms Changes to Board Composition

    Read more
  • Redx Pharma Plc Shares Now Trading on JP Jenkins

    Read more
  • AIM – Cancellation – Redx Pharma Plc

    Read more
  • Update on AIM Delisting

    Read more
  • Result of GM, Cancellation of Admission to Trading

    Read more
  • Update on Broking Arrangements

    Read more